Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China
· Delayed Price · Currency is CNY 42.47
-0.35 (-0.82%)
May 14, 2025, 2:45 PM CST
SHA:688799 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 145.48 | 164.32 | 211.32 | 182.8 | 160.76 | 145.03 | Upgrade
|
| Depreciation & Amortization | 68.9 | 68.9 | 61.02 | 48.79 | 34.22 | 29.67 | Upgrade
|
| Other Amortization | 3.21 | 3.21 | 1.3 | 0.53 | 0.06 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0 | - | 0.18 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.48 | 0.89 | 0.21 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 24.16 | 24.16 | -3.58 | -7.98 | -1.71 | 6.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.31 | 0.31 | 1.47 | 2.23 | 1.31 | 3.1 | Upgrade
|
| Other Operating Activities | -28.25 | -30.16 | -19.19 | -5.34 | 3.08 | 2.35 | Upgrade
|
| Change in Accounts Receivable | -118.65 | -118.65 | -51.33 | 11.32 | -31.56 | -24.17 | Upgrade
|
| Change in Inventory | -55.23 | -55.23 | -31 | -43.25 | -115.58 | 0.99 | Upgrade
|
| Change in Accounts Payable | 106.39 | 106.39 | 50.84 | -34.77 | 66.49 | -58.25 | Upgrade
|
| Operating Cash Flow | 125.3 | 142.23 | 214.44 | 155.65 | 114.72 | 104.66 | Upgrade
|
| Operating Cash Flow Growth | -39.33% | -33.68% | 37.78% | 35.67% | 9.62% | -10.29% | Upgrade
|
| Capital Expenditures | -292.59 | -233.87 | -105.76 | -131.85 | -92.1 | -53.75 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.05 | 0.12 | 0.13 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.07 | - | - | Upgrade
|
| Investment in Securities | 91.34 | 152.79 | 34.47 | -111.7 | -429.6 | -7.5 | Upgrade
|
| Other Investing Activities | -275.91 | -277.76 | 110.37 | 12.74 | 4.26 | 0.09 | Upgrade
|
| Investing Cash Flow | -477.13 | -358.82 | 39.12 | -230.62 | -517.3 | -61.14 | Upgrade
|
| Long-Term Debt Issued | - | 100.61 | 17.11 | - | - | - | Upgrade
|
| Total Debt Issued | 91.31 | 100.61 | 17.11 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 91.31 | 100.61 | 17.11 | - | - | - | Upgrade
|
| Issuance of Common Stock | 9.97 | - | - | - | 674.02 | - | Upgrade
|
| Common Dividends Paid | -86.78 | -86.35 | -84.44 | -65.66 | - | -35.15 | Upgrade
|
| Other Financing Activities | - | - | 9.87 | -10.71 | -18.36 | - | Upgrade
|
| Financing Cash Flow | 14.5 | 14.26 | -57.47 | -76.37 | 655.65 | -35.15 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.34 | 0.42 | 0.01 | 0.53 | -0.03 | -0.28 | Upgrade
|
| Net Cash Flow | -336.99 | -201.91 | 196.11 | -150.82 | 253.04 | 8.09 | Upgrade
|
| Free Cash Flow | -167.29 | -91.65 | 108.68 | 23.8 | 22.63 | 50.91 | Upgrade
|
| Free Cash Flow Growth | - | - | 356.70% | 5.18% | -55.56% | -44.86% | Upgrade
|
| Free Cash Flow Margin | -12.16% | -6.49% | 7.58% | 1.84% | 1.97% | 5.36% | Upgrade
|
| Free Cash Flow Per Share | -1.78 | -0.98 | 1.16 | 0.25 | 0.28 | 0.72 | Upgrade
|
| Cash Income Tax Paid | 197.82 | 198.54 | 192.83 | 152.18 | 132.83 | 119.64 | Upgrade
|
| Levered Free Cash Flow | -274.38 | -166.29 | 69.89 | -40.72 | -33.38 | 5.68 | Upgrade
|
| Unlevered Free Cash Flow | -274.37 | -166.28 | 69.89 | -40.72 | -33.38 | 5.68 | Upgrade
|
| Change in Net Working Capital | 123.78 | 91.48 | 13.52 | 62.55 | 72.99 | 63.64 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.